Cargando…

Case report: Spontaneous remission in lung carcinoma with a late relapse after adjuvant immunotherapy: Exceptional tumor micro-environment

Spontaneous remission (SR) of local recurrence after adjuvant immunotherapy has rarely been reported, and the underlying mechanism is poorly understood. Herein, we reported a patient with stage cT2aN2M0 squamous cell lung carcinoma who received neoadjuvant and adjuvant treatment with nivolumab plus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yan, Guan, Wenhui, Zhong, Changhao, Deng, Jiaxi, Hu, Minjuan, Mo, Wenwei, Xie, Xiaohong, Li, Shiyue, Zhou, Chengzhi, Lin, Xinqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008903/ https://www.ncbi.nlm.nih.gov/pubmed/36923412 http://dx.doi.org/10.3389/fimmu.2023.1106090

Ejemplares similares

Successful management of Epstein‑Barr virus‑associated severe checkpoint inhibitor‑related pneumonitis: A case report
por: Deng, Jiaxi, et al.
Publicado: (2023)

Extracranial abscopal effect induced by combining immunotherapy with brain radiotherapy in a patient with lung adenocarcinoma: A case report and literature review
por: Lin, Xinqing, et al.
Publicado: (2019)

Evaluating relapse-free survival as an endpoint for overall survival in adjuvant immunotherapy trials
por: Li, Yuanfang, et al.
Publicado: (2023)

Successful therapy with bevacizumab combined with corticosteroids for crizotinib-induced interstitial lung disease
por: Xie, Xiaohong, et al.
Publicado: (2019)

Comprehensive Analysis of the Immune Microenvironment in Checkpoint Inhibitor Pneumonitis
por: Lin, Xinqing, et al.
Publicado: (2022)

Exceptional Responder to Immunotherapy: A Rare Case of Post-HSCT DLBCL Relapse Responding to Nivolumab
por: Madabhavi, Irappa, et al.
Publicado: (2019)

Spontaneous Remission in an Older Patient with Relapsed FLT3 ITD Mutant AML
por: Vachhani, Pankit, et al.
Publicado: (2016)

Learning From the Exceptions: HIV Remission in Post-treatment Controllers
por: Etemad, Behzad, et al.
Publicado: (2019)

Treatment response and safety of immunotherapy for advanced non-small cell lung cancer with comorbid chronic obstructive pulmonary disease: a retrospective cohort study
por: Zhang, Kening, et al.
Publicado: (2022)

Very Late Relapse of Acute Promyelocytic Leukemia 17 Years after Continuous Remission
por: Sakurai, Masatoshi, et al.
Publicado: (2018)

Remissions and Relapses in Insular Sclerosis
Publicado: (1904)

Analysis of Adjuvant Chemotherapy on Pathological Remission of Breast Cancer
por: Jiang, Bing, et al.
Publicado: (2021)

A first case report of clinical response to targeted therapy in a patient with primary myoepithelial carcinoma of the lung harboring EGFR exon 19 deletion
por: Xie, Xiaohong, et al.
Publicado: (2020)

An exceptional response to nivolumab in relapsed and refractory malignant mesothelioma
por: Talreja, Vikas T., et al.
Publicado: (2019)

Computational model of CAR T-cell immunotherapy dissects and predicts leukemia patient responses at remission, resistance, and relapse
por: Liu, Lunan, et al.
Publicado: (2022)

Spontaneous remission of African lymphoma.
por: Burkitt, D. P., et al.
Publicado: (1967)

Spontaneous Remission of Isaacs’ Syndrome
por: Uslu, Sadettin, et al.
Publicado: (2019)

Evaluation of Cell Surface Vimentin Positive Circulating Tumor Cells as a Diagnostic Biomarker for Lung Cancer
por: Xie, Xiaohong, et al.
Publicado: (2021)

The clinical analysis of pulmonary lymphoepithelioma-like carcinoma with epithelioid granuloma
por: Gao, Guoying, et al.
Publicado: (2020)

Partial remission, residual symptoms, and relapse in depression
por: Paykel, E.S.
Publicado: (2008)

Diabetes remission and relapse after metabolic surgery
por: Chen, Xiaoping, et al.
Publicado: (2018)

Safety and efficacy of immunotherapy rechallenge following checkpoint inhibitor-related pneumonitis in advanced lung cancer patients: a retrospective multi-center cohort study
por: Lin, Xinqing, et al.
Publicado: (2022)

Successful brentuximab vedotin monotherapy against late relapse of classical Hodgkin lymphoma 6 years after first remission
por: Nagashima, Kana, et al.
Publicado: (2020)

Exceptional Response with Immunotherapy in a Patient with Anaplastic Thyroid Cancer
por: Kollipara, Revathi, et al.
Publicado: (2017)

Kinking graft—an exceptional late complication of axillofemoral bypass grafting
por: Lozano, Francisco, et al.
Publicado: (2020)

Glycemic Status and Predictors of Relapse for Diabetic Cats in Remission
por: Gottlieb, S., et al.
Publicado: (2014)

Unusual Relapse of Chronic Lymphocytic Leukemia After Remission
por: Rizvi, Wajeeha, et al.
Publicado: (2018)

Accessing the exceptional points of parity-time symmetric acoustics
por: Shi, Chengzhi, et al.
Publicado: (2016)

Complete remission after the first cycle of induction chemotherapy determines the clinical efficacy of relapse‐preventive immunotherapy in acute myeloid leukaemia
por: Nilsson, Malin S., et al.
Publicado: (2019)

Case Report: Fatal Multiorgan Failure and Heterochronous Pneumonitis Following Pembrolizumab Treatment in a Patient With Large-Cell Neuroendocrine Carcinoma of Lung
por: Xie, Xiaohong, et al.
Publicado: (2021)

Spontaneous Remission of Solitary-Type Infantile Myofibromatosis
por: Kikuchi, Kazuhiro, et al.
Publicado: (2011)

Spontaneous hematological remission of acute myeloid leukemia
por: Kaźmierczak, Maciej, et al.
Publicado: (2014)

Spontaneous remission of fully symptomatic visceral leishmaniasis
por: Mouri, Oussama, et al.
Publicado: (2015)

Early Spontaneous Remission of Intramyocardial Dissecting Hematoma
por: Miura, Ayako, et al.
Publicado: (2017)

A retrospective real‐world experience of immunotherapy in patients with extensive stage small‐cell lung cancer
por: Qiu, Guihuan, et al.
Publicado: (2023)

NK cell expression of natural cytotoxicity receptors may determine relapse risk in older AML patients undergoing immunotherapy for remission maintenance
por: Martner, Anna, et al.
Publicado: (2015)

Impact of IL-1β and the IL-1R antagonist on relapse risk and survival in AML patients undergoing immunotherapy for remission maintenance
por: Grauers Wiktorin, Hanna, et al.
Publicado: (2021)

Sleeping Beauty: Anesthesia May Promote Relapse in Dogs With Diffuse Large B-Cell Lymphoma in Complete Remission After Chemo-Immunotherapy
por: Faroni, Eugenio, et al.
Publicado: (2021)

SAT-LB71 Is Late Diagnosis of Postsurgical Hypoparathyroidism the Rule, Not the Exception?
por: Fahrleitner-Pammer, Astrid, et al.
Publicado: (2020)

Exploiting antitumor immunity to overcome relapse and improve remission duration
por: Chen, Lei L., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_9dje9r8mf341tqpirokkf29e70